Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Cell therapy demand means CMOs need to up their capabilities, PharmSource

There is a lack of third-party capabilities in the autologous cell therapy space says the new editor of PharmSource ahead of this year’s Interphex Convention.

Pall and Artesyn Biosolutions team to industrialize single-use tech

Pall Corporation and Artesyn Biosolutions will co-develop clinical to commercial-scale solutions for single-use automated bioprocessing systems.

Alexion to pay $855m for Swedish biotech with Ph III candidate

Alexion Pharmaceuticals has announced plans to buy Wilson Therapeutics and its lead candidate WTX101, which has received Fast Track designation.

Shire sells cancer biz for $2.4bn

Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy.

GE launches modular bioprocessing facility for viral vector vaccines

GE Healthcare Life Sciences has launched a prefabricated, modular bioprocessing facility designed for the manufacture of viral vector-based therapeutics.

MilliporeSigma: Filling gaps in continuous bioprocessing will lower COGS

Vendors can help address technology gaps but industry must look to collaborations and internal development to create fully continuous bioprocesses, says MilliporeSigma.

Promotional Features

Content provided by Samsung BioLogics

Samsung BioLogics: The story of the world’s largest biologics manufacturing facility

Samsung BioLogics has moved quickly since it began operating in 2011. The South Korean contract development and manufacturing organization (CDMO) has built a series of progressively larger, more advanced facilities, culminating in its 180,000L “Dream...